Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection

Journal of Korean Medical Science

Volumn 31, Issue 11, 2016, Pages 1717-1725

  Kim, Eu Suk ^a   Choe, Pyoeng Gyun ^a   Park, Wan Beom ^a   Oh, Hong Sang ^a   Kim, Eun Jung ^a   Nam, Eun Young ^a   Na, Sun Hee ^a   Kim, Moonsuk ^a   Song, Kyoung Ho ^a   Bang, Ji Hwan ^a   Park, Sang Won ^a   Kim, Hong Bin ^a   Kim, Nam Joong ^a   Oh, Myoung Don ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Chemokine; Clinical progression; Coronavirus; CXCL 10; Cytokine; IFN ; IL 6; MERS; Severity

Indexed keywords

CHEMOKINE; CREATININE; CXCL10 PROTEIN, HUMAN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6;

ADULT; AGED; BLOOD; BODY TEMPERATURE; COMPLICATION; CORONAVIRUS INFECTION; CYTOLOGY; DISEASE COURSE; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERBARIC OXYGEN THERAPY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BODY TEMPERATURE; CHEMOKINE CXCL10; CHEMOKINES; CORONAVIRUS INFECTIONS; CREATININE; CYTOKINES; DISEASE PROGRESSION; DYSPNEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERBARIC OXYGENATION; INTERFERON-GAMMA; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX;

EID: 84995442519     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2016.31.11.1717     Document Type: Article

References (26)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-20.
2. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)-Saudi Arabia: disease outbreak news, 14 April 2016 [Internet]. Available at http://www.who.int/csr/don/14-april-2016-mers-saudi-arabia/en/[updated on 14 April 2016; accessed on 20 April 2016].
3. Lee J. Better understanding on MERS corona virus outbreak in Korea. J Korean Med Sci 2015; 30: 835-6.
4. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015; 6: 269-78.
5. Oh MD, Choe PG, Oh HS, Park WB, Lee SM, Park J, Lee SK, Song JS, Kim NJ. Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015. J Korean Med Sci 2015; 30: 1701-5.
6. World Health Organization. Summary and risk assessment of current situation in Republic of Korea and China: MERS-CoV risk assessment, 19 June 2015 [Internet]. Available at http://who.int/csr/disease/coronavirus_infections/risk-assessment-19june2015/en/[updated on 19 June 2015; accessed on 17 September 2015].
7. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-7.
8. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, Ren Y, Wang J, Dong Y, Bao M, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 2014; 111: 769-74.
9. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136: 95-103.
10. Oh MD, Park WB, Choe PG, Choi SJ, Kim JI, Chae J, Park SS, Kim EC, Oh HS, Kim EJ, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med Forthcoming 2016.
11. Park WB, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, Oh HS, Song KH, Bang JH, Kim ES, et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis 2015; 21: 2186-9.
12. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus: interim guidance [Internet]. Available at http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en/[updated on June 2015; accessed on17 September 2015].
13. Wang WK, Chen SY, Liu IJ, Kao CL, Chen HL, Chiang BL, Wang JT, Sheng WH, Hsueh PR, Yang CF, et al. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis 2004; 39: 1071-5.
14. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752-61.
15. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-16.
16. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767-72.
17. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MA, Al Mutairi M, Al Nakhli D, Al Aidaroos AY, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014; 29: 301-6.
18. Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, Memish ZA. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 2014; 59: 160-5.
19. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160: 389-97.
20. Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. MBio 2014; 5: e01174-14.
21. Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R, et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One 2014; 9: e88716.
22. Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis 2007; 45: 723-31.
23. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011; 6: e26050.
24. Chi Y, Zhu Y, Wen T, Cui L, Ge Y, Jiao Y, Wu T, Ge A, Ji H, Xu K, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis 2013; 208: 1962-7.
25. Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, Sun T, Lau CC, Wong KK, Chan JY, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis 2014; 209: 1331-42.
26. de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, Fischer ER, Martellaro C, Okumura A, Chang J, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 2013; 110: 16598-603.